Remote pathogen eradication
11554187 · 2023-01-17
Inventors
- Israel Nissenbaum (Brooklyn, NY, US)
- Mitchell J. Bogart (New Haven, CT, US)
- Asher Baum (Brooklyn, NY, US)
Cpc classification
A61B90/70
HUMAN NECESSITIES
A61B1/07
HUMAN NECESSITIES
A61L2202/24
HUMAN NECESSITIES
A61B2090/701
HUMAN NECESSITIES
A61L2202/11
HUMAN NECESSITIES
International classification
A61L2/00
HUMAN NECESSITIES
G01N21/00
PHYSICS
A61B18/18
HUMAN NECESSITIES
A61B1/00
HUMAN NECESSITIES
Abstract
A method and device for the remote eradication of pathogens comprising a light source for emitting UV light in the pathogen killing wave length range, and a tangible transmission medium, which is at least initially resistant to degradation by the UV light. An optical interface between the UV light source and the tangible transmission medium is provided whereby the emitted UV light is collected from the light source and transmitted through the tangible transmission medium, whereby UV light emitted from the tangible transmission medium and directed against a pathogen in proximity thereto is at a power level sufficient to substantially effectively kill the pathogen within a reasonable period of time. The device is used for sanitization of biopsy channels of endoscopes and for treating of pathogens within humans and animals.
Claims
1. A method for disinfecting pathogens from pathogen infected areas inaccessible to direct UV light, comprising the steps of: i) optically combining UV light source, with a power output of at least 2 mW, with a UV light output at a wave length level which provides pathogen deactivation by RNA and/or DNA disruption, with a proximal end of a tangible transmission medium, capable of transmitting UV light emitted from the UV light source and having a proximal and distal end, and fiber having an acceptance angle at the proximal end, for the UV light at the UV wave length level between, the optical combining being effected by means of an optically aligned optical interface between the UV light source and the proximal end of the tangible transmission medium, whereby emitted UV light from the light source is directed within the acceptance angle and transmitted through the fiber optic cable tangible transmission medium and emitted out of the second distal end thereof, ii) providing the tangible transmission medium with a UV light collection structure for collecting the UV light emitted from the light source at the proximal end thereof into the acceptance angle and for emitting collected UV light output at a movable distal end thereof, to which output UV light is transmitted, iii) providing the UV light source and the tangible transmission medium with a jig structure which holds and maintains a fixed relative distance and position, with optical alignment, between the proximal end of the tangible transmission medium and the UV light source in the optical interface, with the distal end being movable, and wherein UV light direction and optical alignment are not disrupted with movement of the distal end of the tangible transmission medium, wherein the jig structure comprises: a) a holding element which is fixedly engaged with the proximal end of the tangible transmission medium, b) a support element for the UV light source and c) a position fixed spacer structure between the UV light source and the proximal end of the tangible transmission medium, iv) configuring and dimensioning at least a portion of the distal end of the tangible transmission medium to be capable of being inserted into or adjacent an otherwise inaccessible pathogen infected or possibly pathogen infected area, to an extent that light transmitted through the tangible transmission medium and emitted out of the distal end is able to effectively reach pathogens of the pathogen infected or possibly infected area; v) providing the emitted UV light from the distal end with a power intensity sufficient to disinfect the pathogen infected or possibly infected area from pathogens at a desired proximate distance and within a desired reasonable time period; and vi) inserting the distal end of the tangible transmission medium into or directly adjacent to the pathogen infected or possibly infected area and providing UV light thereto with the sufficient power level intensity at the desired proximate distance.
2. The method of claim 1, wherein the pathogen infected area or possibly pathogen infected area is human or animal blood, within the human or animal, and the distal end of the tangible transmission medium is inserted within a blood vessel of the human or animal and wherein blood circulation brings infecting pathogens into proximity to UV light emitted from the distal end of the tangible transmission medium.
3. The method of claim 1; with the further steps of the distal end of the tangible transmission medium being moved to at least one other pathogen infected or possibly pathogen infected area and transmitting disinfecting UV light through the tangible transmission medium whereby the UV light impinges on the at least one other pathogen infected or possibly pathogen infected area at a desired distance from the distal end and for the desired time sufficient to acceptably disinfect the at least one other pathogen infected or possibly pathogen infected area.
4. The method of claim 1, wherein the pathogen infected or possibly pathogen infected area is at least one of an instrument channel, suction channel, combined instrument and suction channel, water channel and air channel of an endoscope.
5. The method of claim 1, wherein the UV light collection structure is configured to provide the steps of: i) collecting and collimating scattered UV light emitted from a widely scattering non-coherent light source LED to a diameter effective to permit capture by the tangible transmission medium which is comprised of a fiber optic cable of a substantial portion of non-coherent light emitted by the LED light source; ii) introducing the collimated light into the low UV attenuation light transmitting fiber optic cable of a diameter at least substantially equal to that of the collimated light; iii) focusing the collimated light to a focal point into a smaller diameter fiber optic cable of desired size; and iv) emitting light from the smaller diameter fiber optic cable for pathogen deactivation.
6. A method of increasing pathogen eradicating distal UV light output in the method of claim 1, comprising the steps of: a. collimating a substantial portion of UV light output from the LED by optically integrating the LED with a collimating member having a light output diameter greater than that of a die of the LED; b. collecting a substantial portion of the collimated UV light with a light collector and transmitter element having a low UV light attenuation transmission, with the light collector and transmitter having a diameter optically matched to the light output diameter of the collimating member; c. and transmitting and focusing the collected collimated light into the proximal end of the fiber optic transmission cable with a distal end light output of UV against a pathogen in proximity thereto.
7. The method of claim 1, wherein the pathogen infected area is infected with mold, fungus or mildew.
8. A method for the remote eradication of pathogens within a human or animal in accordance with the method of claim 1 wherein the tangible transmission medium comprises a fiber optic cable having been provided with an integral treatment for radial UV light diffusion, comprising the steps of: i) inserting the fiber optic cable into an endoscope; ii) steering the endoscope within the human or animal to a site possibly infected with a pathogen; iii) extending the distal end of the fiber optic cable out of a distal end of the endoscope; iv) radially emitting the UV light against a proximate pathogen infected or possibly pathogen infected area.
9. The method of claim 1 wherein the tangible transmission medium is comprised of a fiber optic cable with the distal end of the fiber optic cable being provided with an integral treatment for radial UV light diffusion.
10. A device for the remote eradication of pathogens comprising: a) a UV light source, comprising a laser, or an LED, each with a power output of at least 2 mW, with a UV light output at a wave length level which provides pathogen deactivation by RNA and/or DNA disruption, b) a tangible solid or liquid transmission medium, having a proximal end and a distal end, which tangible transmission medium is capable of transmitting UV light emitted from the UV light source, and the transmission medium having an acceptance angle for the UV light, and an optical interface between the laser or LED UV light source and the tangible transmission medium whereby emitted UV light from the UV light source is directed to the proximal end of the transmission medium within the acceptance angle, whereby the directed UV light is transmitted through the tangible transmission medium, wherein the optical interface provides a fixed, optical alignment for the direction of emitted UV light from the UV light source within the acceptance angle of the transmission medium, and c) the device having a jig structure which holds and maintains a fixed relative distance and position, with optical alignment, between the proximal end of the transmission medium and the UV light source in the optical interface, with the distal end being movable and wherein UV light direction and optical alignment are not disrupted with movement of the distal end of the transmission medium, wherein the jig structure comprises: i) a holding element which is fixedly engaged with the proximal end of the transmission medium, ii) a support element for the UV light source and iii) a position fixed spacer structure between the UV light source and the proximal end of the transmission medium, wherein UV light emitted from the distal end of the tangible transmission medium, which distal end is movable and moved and directed against pathogens in proximity thereto, is at a UV power level sufficient to substantially effectively deactivate RNA and/or DNA of the pathogens within a reasonable period of time.
11. The device of claim 10, wherein the light source for emitting UV light comprises at least one UV light emitting diode (LED) comprising a light emitting die, wherein the tangible transmission medium comprises a low UV attenuation, solarization resistant, fiber optic cable comprised of at least one segment, and wherein the optical interface comprises an acceptance angle aligned optical connection between the UV light emitting die and the fiber optic cable selected from at least one of a direct butt coupling between the fiber optic cable and the light emitting die; and a light collecting and light collimating lens system which collects light from the light emitting die and collimates it for transmission and directs it to the proximal end of the fiber optic cable within the UV light acceptance angle.
12. The device of claim 11, wherein the light emitting diode provides a UV light emission output at a wave length level between 250 nm and 285 nm, with a power output of at least 40 mW and wherein UV light emitted from the fiber optic cable and directed against the pathogen, in proximity thereto, is at a level of at least 2 mW/cm.sup.2.
13. The device of claim 11, wherein UV light emitted from the LED is captured, collimated and focused into the proximal end of the light transmission fiber with a TIR lens optically connected with the LED.
14. The device of claim 11, wherein UV light emitted from the distal end of the fiber optic cable, and directed against a pathogen in proximity thereto, is configured to be at a power level of at least 2 mW/cm.sup.2.
15. The device for eradication of pathogens of claim 10, wherein the tangible UV light transmission medium is comprised of a UV light transmitting lens.
16. A remote pathogen eradication device in combination with an endoscope, with the device comprising a UV light source optically coupled to a tangible UV light transmission medium capable of transmitting a UV light emitted from the light source, the tangible UV light transmission medium having a proximal and distal end, with the distal end being movable and configured to be carried and steered within a human body or animal to a pathogen infected area or possibly infected area therein by the endoscope having an instrument insertion channel therein and with the tangible UV light transmission medium having sufficient flexibility for steered positioning thereof by the carrying endoscope, wherein the tangible UV light transmission medium is configured to be insertable into the instrument insertion channel and movably retained therein, for positioning emitted UV light emission from the distal end to the pathogen infected area or possibly pathogen infected area within the human or animal for pathogen eradication at the infected site and wherein the tangible UV light transmission medium is extendible and retractable within the insertion channel for closer positioning of UV light emission from the distal end to the infected site, wherein the device comprises: a) a UV light source, with a UV light output at a wave length level providing pathogen deactivation by RNA and/or DNA disruption, b) a tangible solid or liquid UV light transmission medium, capable of transmitting UV light emitted from the UV light source, which has an acceptance angle for the UV light at the wave length level, and c) an optical interface between the UV light source and the proximal end of the tangible UV light transmission medium whereby emitted UV light from the light source is directed to the proximal end within the acceptance angle whereby the directed UV light is transmitted through the tangible UV light transmission medium, wherein the optical interface provides a fixed, optical alignment for the direction of emitted UV light from the UV light source within the acceptance angle of the tangible UV light transmission medium, and d) the device having a jig structure which holds and maintains a fixed relative distance and position, with optical alignment, between the proximal end of the tangible UV light transmission medium and the UV light source in the optical interface, whereby UV light direction and optical alignment are not disrupted with movement of the distal end of the tangible UV light transmission medium within the instrument insertion channel, wherein the jig structure comprises: i) a holding element which is fixedly engaged with the proximal end of the tangible UV light transmission medium, ii) a support element for the UV light source and iii) a position fixed spacer structure between the UV light source and the proximal end of the tangible UV light transmission medium, wherein UV light emitted from the movable distal end of the tangible UV light transmission medium which is moved into proximity and directed against pathogens is at a UV light power level sufficient to substantially effectively deactivate RNA and/or DNA of the pathogens within a reasonable period of time.
17. The device of claim 16, wherein the light source for emitting UV light comprises at least one light emitting diode (LED) comprising a light emitting die, and wherein the tangible transmission medium comprises a low UV attenuation fiber optic cable comprised of at least one segment.
18. The device of claim 17, wherein the fiber optic cable is configured to be carried and steered within a human or animal to a cancer infected site therein within an aspiration needle having a hollow therein and the needle being configured for positioning and insertion directly into a cancer infected site, wherein a portion of the fiber optic cable is dimensioned to be insertable into the hollow of the needle and movably retained therein, whereby a distal section of the fiber optic cable is extendible and retractable from within the hollow of the needle, with the needle having been inserted into a cancer infected site, whereby the fiber optic cable is positionable, with extension from the needle, for emitting UV light directly into the cancer infected site for inactivation of cancer cells at the cancer infected site.
Description
SHORT DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
(33)
(34)
(35)
(36)
(37)
(38)
(39)
(40)
(41)
(42)
(43)
(44)
(45)
(46)
DETAILED DESCRIPTION AND DESCRIPTION OF THE DRAWINGS
(47) With reference to the drawings,
(48)
(49) A typical bronchoscope endoscope 7 used in embodiments of the invention for carrying light transmitting fibers and which is difficult to sterilize is shown in
(50)
(51)
(52)
(53)
(54)
(55)
(56)
(57)
(58) Similar
(59)
(60)
(61) Since water pipes are of much larger dimensions than those of biopsy/suction channels, UV emitting LEDs are able to be directly placed in a circular cylindrical structure 82 as shown in
(62)
(63)
(64)
(65)
(66)
(67)
(68)
(69)
(70)
(71)
(72)
(73)
EXAMPLES
Example 1
(74) The 75 mW 265 nm LED of
Example 2
(75) As shown in a virtual simulation in
Example 3
(76) Similarly,
(77) A ray tracing procedure was effected with respect to the procedure described in Examples 2 and 3 and as illustrated in
(78) The ray tracing is a simulation of radiation pattern based on the following and as performed with non sequential Zemax simulation software: 1. With reference to
(79) Procedure of Butt Coupling a LED and a Fiber—Analysis, Simulation, and Measurement:
(80) Delivering UV light through a medium, in this case starting from an LED source and transmitting the light into a fiber optic cable, begins with the coupling of a die of an LED and the fiber. A simple and straightforward method of implementing this, though not necessarily the best or most efficient is by using the method of “butt coupling”. In this procedure a proximal end of the fiber is brought into close contact with the die of the LED as closely as possible since actual touching is detrimental to the integrity of the die (which is normally protectively covered in any event). Since LED light spreads out widely from the die component inside the LED, typically at a 120° to 130° angle, it is efficacious to allow as little of angular expansion to occur as possible by starting the coupling close to the die before the light has a chance to spread. Emissions and effectiveness of the coupling are evaluated herein in three ways, which are in close agreement with each other: 1. Ray tracing simulation—involving the simulation of the light source as a source of typically millions of rays coming out in all possible directions and flowing them to see how and if they enter the simulated fiber aperture. 2. Actual measurements of known LEDs and fiber configurations—The LED dies have a variety of sizes (square) and power (emitted) and the fiber optic cables have a variety of core sizes. The fibers used are short and have low attenuation for the UV light used. The power out of the raw LED as well as the out of the fiber(s) coupled to the LED were measured with an “integrating sphere” type of radiometer, which is similar to how the power of LEDs is specified by their manufacturer. This produces the highest values, but takes into account all the radiated output, regardless of direction. The conclusions derived from these tests are used only for relative coupling efficiency percent (100×Power Out/Power In). Since difficult to obtain special UV versions of such a radiometer was not available, a much less sensitive visible light version was used on a correlative basis since, regardless of the absolute power reported, the efficiency (a ratio, or relative calculation) is regarded as correct.
As support for this, the sensitivity graph of the ThorLabs S142C integrating sphere sensor for the Thor PM320E radiometer used is shown as
The following are analyses and comparisons of the LEDs and cables as Examples 4-10:
Example 4
(81) A Ray tracing simulation of a 1 Watt 120° LED into a 1 mm fiber with large aperture was used to determine coupling efficiency LED Power out/Fiber Power in.
Example 5
(82) A Ray tracing simulation of a 1 Watt 120° LED into a 2 mm fiber with large aperture was used to determine coupling efficiency LED Power out/Fiber Power in.
Example 6
(83) 2000 um, 3000 um and 4000 um fibers, of two different Numeric Apertures were measured, butt coupled to a UV-C LED, with methods sufficient for measuring relative efficiency (ratio of Power out/Power in), as previously mentioned.
Example 7
(84) A 360 mW LED die that is 4 mm×4 mm butt coupled to a 1 mm fiber is analyzed using area covering ratios to determine additional losses due to non-covered light.
Example 8
(85) A 360 mW LED die that is 3 mm×3 mm butt coupled to a 1 mm fiber is analyzed using area covering ratios to determine additional losses due to non-covered light.
Example 9
(86) A 75 mW LED die that is 1.2 mm×1.2 mm butt coupled to a 1 mm fiber is analyzed using area covering ratios to determine additional losses due to non-covered light.
Example 10
(87) A 90 mW LED die that is 1.38 mm×1.38 mm butt coupled to a 1 mm fiber is analyzed using area covering ratios to determine additional losses due to non-covered light.
(88) Results:
(89) Example 4—This ray tracing,
(90) Example 5—This ray tracing,
(91) Example 6—A 3000 um NA 0.28 cable had a measured efficiency of 23%.
(92) A 4000 um NA 0.22 cable had a measured efficiency of 32%. (the largest diam. cable)
(93) A 2000 um NA 0.28 cable had a measured efficiency of 22%.
(94) A 2000 um NA 0.22 cable had a measured efficiency of 24%.
(95) From these measurements, made with an integrating sphere radiometer, the value 22% can be used as a guide for how much of the total LED irradiation comes through a fiber, butt-coupled to an LED.
(96) Example 7—360 mW LED die that is 4 mm×4 mm butt coupled to a 1 mm fiber area ratio analysis: The 4 mm square die has an area of 16 mm2 (square millimeters). The 1 mm fiber, having a radius of 0.5 mm has an area of PI*(0.5)2=0.785 mm2 That area is 4.91% of 16 mm2. 4.91% of 22%=1.1% coupling efficiency.
Example 8—1% of 360 mW is 3.89 mW out.
Relative size of the round 1 mm diameter fiber over a 4 mm square LED die.
Example 9—360 mW LED die that is 3 mm×3 mm butt coupled to a 1 mm fiber area ratio analysis:
The 3 mm square die has an area of 9 mm2 (square millimeters).
The 1 mm fiber, having a radius of 0.5 mm has an area of PI*(0.5)2=0.785 mm2.
That area is 8.72% of 9 mm2.
8.72% of 22%=1.92% coupling efficiency
1.92% of 360 mW is 6.91 mW out.
Relative size of the round 1 mm diameter fiber over a 3 mm square LED die.
Example 10—75 mW LED die that is 1.2 mm×1.2 mm butt coupled to a 1 mm fiber area ratio analysis:
The 1.2 mm square die has an area of 1.44 mm2 (square millimeters).
The 1 mm core fiber, having a radius of 0.5 mm has an area of PI*(0.5)2=0.785 mm2.
That area is 54.5% of the 1.44 mm2.
54.5% of 22%=12.0% coupling efficiency
12.0% of 75 mW is 8.99 mW out of the fiber.
Relative size of the round 1 mm diameter fiber over a 1.2 mm square LED die.
The above cited IEEE study used a single 18 mW 275 nm LED at a distance of 3 cm, releasing 600 mJ max of energy in 30 seconds to reduce Covid virus by 99.9%.
At the distance of 3 cm from the irradiated surface, the 120° wide emitted light covers a circular area of radius 2.6 cm (diameter 5.2 cm), thus having an illuminated area (Pi r2) of 21.2 cm2.
The 75 mW LED is at 265 nm has about 25% more efficacy than 275 nm, thus this LED is to be considered as providing 11.2 mW. At 3 cm distance, 600 mJ of energy would take 600 mJ/(11.2 mJ/sec)=53.6 seconds and able to sanitize a spot 5.2 cm in diameter.
At 2 cm distance, ⅔ times as close, the time would be (⅔)2, 0.44 times shorter=23.6 s and able to sanitize a spot 3.5 cm in diameter.
At 1 cm distance, ⅓ times as close, the time would be (⅓)2, 0.109 times shorter=5.84 s and able to sanitize a spot 1.73 cm in diameter.
At 2 mm distance, 1/15 times as close, the time would be ( 1/15)2, 0.0044 times shorter=0.238 s and able to sanitize a spot 0.35 cm (3.5 mm) in diameter.
Example 11-90 mW LED die that is 1.38 mm×1.38 mm butt coupled to a 1 mm fiber area analysis:
The 1.38 mm square die has an area of 1.90 mm2 (square millimeters). The 1 mm fiber, having a radius of 0.5 mm has an area of PI*(0.5)2=0.785 mm2 That area is 41.3% of 1.90 mm2.
41.3% of 22%=9.10% coupling efficiency and 9.10% of 90 mW is 8.12 mW out.
Relative size of the round 1 mm diameter fiber over a 1 mm square LED die.
Example 12—75 mW LED die that is 1.2 mm×1.2 mm butt coupled to a 500 um fiber—area ratio analysis: The 1.2 mm square die has an area of 1.44 mm2 (square millimeters). The 500 um core fiber, having a radius of 0.250 mm, has an area of PI*(0.25)2=0.196 mm2. That area is 13.6% of the 1.44 mm2. 13.6% of 22%=3.0% coupling efficiency with 3.0% of 75 mW is 2.25 mW out of the fiber.
(97) Relative size of the round 0.5 mm diameter fiber core over a 1.2 mm square LED die. The 75 mW LED is at 265 nm which has about 25% more efficacy than 275 nm this LED is to be considered as 2.81 mW. At 3 cm distance, 600 mJ of energy would take 600 mJ/(2.81 mJ/sec)=213.5 seconds and is able to sanitize a spot 5.2 cm in diameter. At 2 cm distance, ⅔ times as close, the time would be (⅔)2, 0.44 times shorter=94.0 s and able to sanitize a spot 3.5 cm in diameter. At 1 cm distance, ⅓ times as close, the time would be (⅓)2, 0.109 times shorter=40.6 s and able to sanitize a spot 1.73 cm in diameter. At 2 mm distance, 1/15 times as close, the time would be ( 1/15)2, 0.00444 times shorter=0.949 s and able to sanitize a spot 3.5 mm in diameter.
Calculation for Disinfection of a 2 mm Diameter Biopsy Channel 660 mm Long Using a 1 mm O.D. Version of the Sanitizing Cable
(98) From the IEEE study, a 275 nm, 120° emitting, 20 mW LED, used for 30 sec at a distance of 3 cm, deactivated a culture of Covid 19 Sars virus by 99.9%.
(99) A distance of 3 cm from a 120° spreading light produces a circular irradiation area of 21.2 cm.sup.2. The radius at that distance is 2.6 cm. The area, Pi R squared, is 2,123 square mm.
(100) (Note—Units are in parenthesis and a mW of power is the same as a mJ/second)
Energy(mJ)=Intensity(mW/cm.sup.2or mJ/sec/cm.sup.2)×(Time(sec)×Area(cm.sup.2))
I) For the IEEE study, to find the Intensity used, we solve for Intensity and use:
Intensity=Energy/(Time×Area),which in the study is:
Intensity=600mJ/(30 sec×21.2 cm.sup.2)=0.94 mW/cm.sup.2or about1 mW/cm.sup.2
The IEEE study used about 1 mW per square centimeter for 30 seconds.
II) The invention's UV light through a fiber into a biopsy channel.
Calculating the surface area inside the 2 mm diameter biopsy channel is done as follows:
For calculations of area, a cylindrical tube surface is “cut” along a longitudinal dotted line and unrolled into a flat rectangle like a label of a can. That rectangle's length and width are, respectively, the length of the tube and the circumference of the tube, illustrated below.
That rectangle has a length of 660 mm (26 inches) and a width which is the biopsy channel circumference.
The radius of the channel is 1 mm, so the circumference, (2 Pi r), is 6.3 mm.
That rectangle area is therefore 660×6.3=4,158 mm.sup.2, or 41.58 cm.sup.2.
Measurements were made of the light from a 1.2 mm square 75 mW LED emitter, butt-coupled into a 600 um core fiber optic cable, which showed an emerging intensity of 14.4 mW/cm.sup.2. Accounting for the 265 nm 25% benefit over 275 nm, that is an effective 18.0 mW/cm.sup.2.
If the same amount of Covid 19 virus in the study were inside the biopsy channel, 99.9% reduction would take 0.8 seconds by the following calculation:
Definition of Intensity, Converted to Energy: (Units in Parenthesis)
Energy(mJ)=Intensity(mJ/sec/cm.sup.2))×Time(sec)×Area(cm.sup.2)
Solving for time,
Time(sec)=Energy/(Intensity×Area)
In our case, the specifics are:
Time=600mJ/(18 mW/cm.sup.2×41.58 cm2)=0.80 seconds
At these levels and especially with higher power LEDs, at similar close range, delivery of sufficient UV-C light in reasonable time to kill a malignant lymph node becomes possible. These nodes are already discovered, categorized, and repeatably located, using mature EBUS (EndoBronchial UltraSound) technology and UV-C delivery fiber cables inserted inside the 1 mm I.D. aspirating needles, which themselves have been inserted through an endoscope biopsy channel and guided precisely via ultrasound to where UV-C delivery is needed, right inside a malignant lymph node, accessed from within pulmonary bronchi.
(101) An additional butt coupling assembly is shown in
(102)
(103)
(104)
(105) It is understood that the above descriptions, figures, and examples are only illustrative of the invention and that changes in structure, composition and components of the device and steps and requirements of the method are only illustrative and that changes may be made without departing from the scope of the invention as defined in the following claims.